MURIPOCIN 2% w/w Ointment Ref.[7728] Active ingredients: Mupirocin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: Focus Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, United Kingdom

Product name and form

Mupirocin 2% w/w Ointment.

Pharmaceutical Form

Ointment in a white, translucent, water-soluble, polyethylene glycol base.

Qualitative and quantitative composition

Each gram of ointment contains 20 mg mupirocin (2% w/w mupirocin).

For the full list of excipients, see Section 6.1.

Active Ingredient Description
Mupirocin

Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally.

List of Excipients

Macrogol 400
Macrogol 3350

Pack sizes and marketing

15g aluminium tube internally coated with an epoxy non-toxic resin closed with polyethylene screw caps.

Marketing authorization holder

Focus Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, United Kingdom

Marketing authorization dates and numbers

PL 20046/0071

16/12/2011

Drugs

Drug Countries
MUPIROCIN Austria

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.